OpenAI 2026 hackathon

Pathflow

A living pathology laboratory operating system built by a practicing pathologist in Ethiopia using Codex to solve real workflow, reporting, inventory, and turnaround-time problems.

Solo project by Samuel Addisu · 0 likes · 0 comments

Archive position — measured, not model output

0 likes on Devpost

2,264 of the 7,856 archived projects have more likes, and 5,592 share exactly 0 — so this project's #5,850 place in the like-ranked listing is a tie-break inside that group, not a ranking.

Projects (log scale)

1
10
100
1k
10k
05,592
11,758
2285
3–4132
5–975
10+14

Likes on Devpost. ▲ marks this project's group.

Show the figures
LikesProjectsShare of archive
05,59271.2%
11,75822.4%
22853.6%
3–41321.7%
5–9751.0%
10+140.2%
Devpost like counts for all 7,856 archived projects, captured when this archive was built.

Executive Summary

What the company appears to be

Pathflow is a self-reported pathology laboratory information system (LIS) built by a single practicing pathologist in Ethiopia using AI-assisted coding tools (Codex, GPT-5.6). The author states it provides role-based access, case tracking, reporting workflows, inventory monitoring, and analytics for turnaround time and resource costs.

What changed

The project description indicates that Pathflow evolved from an early prototype into a deployed application during a Build Week hackathon using AI coding tools. It includes new features like overdue-case highlighting, filtered analytics, and improved deployment.

Single most important open question — the commercial due-diligence read

Is there evidence of actual use or adoption by users beyond the author? The description states no revenue, customers, or traction data exist beyond what is self-reported.

Back to contents

What The Product Actually Is

The description states that Pathflow is a role-based pathology laboratory workflow and resource-management platform. It includes:

  • Separate user privileges for employees, administrators, and pathologists
  • Case registration and workflow tracking
  • Predictive search for gross and microscopic templates
  • Faster retrieval/editing of standardized reporting text
  • Patient-record similarity alerts
  • Inventory tracking
  • Resource expenditure calculation per case
  • Turnaround-time monitoring and statistics
  • Automatic red highlighting of unresolved cases pending more than four days
  • Filtered case analytics by date range, pathologist, clinic, age, tumor site, diagnosis
  • Clickable summary statistics that open underlying case lists

The author describes it as a deployed application with working PostgreSQL database, role-based accounts, structured case registration, reporting workflows, and analytics.

Evidence Author's own description

Inference Not evidenced

Back to contents

Positioning & Claim Evolution

The author positions Pathflow as:

  • A living pathology laboratory operating system
  • Built by a practicing pathologist in Ethiopia
  • Using AI tools (Codex, GPT-5.6) to solve real workflow and reporting problems
  • Designed for environments with limited access to traditional software or IT support
  • Demonstrating that domain experts can build solutions when given powerful coding tools

The project evolved from an idea to a working prototype, then to a deployed application during Build Week.

Claim

The author claims this represents a new model of software creation where domain experts use AI to build systems tailored to their needs.

Evidence Author's own description

Inference Not evidenced

Back to contents

Target Customer & ICP

The description states that Pathflow is intended for pathology laboratories, particularly those in resource-constrained settings like small towns in Ethiopia, where access to specialized technology or commercial LIS systems is limited due to geography and cost.

It targets users who are:

  • Practicing pathologists
  • Laboratory staff (employees, administrators)
  • Institutions needing case tracking, reporting, inventory control, and turnaround-time monitoring

The author emphasizes that the system was built for a specific local context — a small town in Ethiopia — rather than a broad market.

Evidence Author's own description

Inference Not evidenced

Back to contents

Business Model & Pricing Evidence

There is no evidence provided about pricing or business model. The author does not state whether Pathflow will be sold, licensed, offered as open source, or used internally within one laboratory.

Evidence Not evidenced

Inference Not evidenced

Back to contents

Technical & Delivery Signals

The system was built using:

  • Python
  • Flask
  • PostgreSQL
  • SQLAlchemy
  • HTML/CSS/JavaScript
  • Visual Studio Code
  • OpenAI Codex
  • GPT-5.6
  • Gunicorn, Waitress
  • Railway

The author reports that:

  • The application is deployed on Railway with PostgreSQL
  • It includes role-based access control
  • It supports database modeling, query improvement, and debugging via Codex
  • Deployment involved handling environment variables, database drivers, and production server configuration

Evidence Author's own description

Inference Not evidenced

Back to contents

Traction & Maturity Signals

The author states that Pathflow is:

  • A deployed application
  • Has a working PostgreSQL database
  • Supports role-based user accounts
  • Includes case registration, reporting workflows, analytics, inventory tracking, and cost analysis

However, there is no evidence of:

  • Revenue
  • Customers or users beyond the author
  • Adoption metrics
  • Growth data
  • Product usage statistics

Evidence Author's own description

Inference Not evidenced

Back to contents

Competitive Context

The description does not mention competitors or existing solutions in the pathology LIS space. It focuses on how Pathflow was built using AI tools and tailored for a specific, underserved market.

No comparison to commercial systems or open-source alternatives is made.

Evidence Not evidenced

Inference Not evidenced

Back to contents

Key Risks & Red Flags

  • Single-founder model: Only one person (Samuel Addisu) is involved.
  • No verified users or customers: No evidence of actual use beyond the author’s own laboratory.
  • Unverified claims: All statements are self-reported and unverified.
  • Limited scalability assumptions: The system was built for a single lab in a small town — no indication it has been scaled or adapted for broader use.
  • AI dependency risk: Reliance on Codex, GPT-5.6 may not be sustainable long-term if these tools change or become unavailable.

Evidence Author's own description

Inference Not evidenced

Back to contents

Diligence Questions To Ask The Founders

  1. How many pathology laboratories currently use Pathflow?
  2. What is the actual workflow problem that Pathflow solves, and how does it differ from existing solutions?
  3. Are there any plans to monetize or scale the platform beyond one lab?
  4. Has the system been tested by other pathologists or users outside of the author’s own practice?
  5. How is data security handled in a resource-constrained environment?
  6. What are the long-term sustainability risks related to AI tool dependencies (e.g., Codex, GPT-5.6)?
  7. Is there any plan for integration with digital pathology or imaging systems?

Evidence Not evidenced

Inference Not evidenced

Back to contents

Investment/Partnership Verdict

There is no evidence of traction, revenue, or customer adoption beyond the author’s own use case. The project is described as a self-built prototype, deployed during a hackathon, and not yet validated in any commercial or institutional setting.

The author claims that AI tools enabled him to build a functional system without formal software training — an impressive feat but not sufficient proof of viability or scalability for investment or partnership.

Verdict Not evidenced

Confidence Low

Back to contents

Source

Submitted to the OpenAI 2026 hackathon on Devpost. Project home on DevPost.

The analysis above was generated by a language model from the project's own one-line description. It is not independent research and contains no verified traction, revenue or customer data.